Literature DB >> 11499870

Characterization of tissue transglutaminase in human osteoblast-like cells.

D J Heath1, S Downes, E Verderio, M Griffin.   

Abstract

Tissue transglutaminase (tTG) is a calcium-dependent and guanosine 5'-triphosphate (GTP) binding enzyme, which catalyzes the post-translational modification of proteins by forming intermolecular epsilon(gamma-glutamyl)lysine cross-links. In this study, human osteoblasts (HOBs) isolated from femoral head trabecular bone and two osteosarcoma cell lines (HOS and MG-63) were studied for their expression and localization of tTG. Quantitative evaluation of transglutaminase (TG) activity determined using the [1,4 14C]-putrescine incorporation assay showed that the enzyme was active in all cell types. However, there was a significantly higher activity in the cell homogenates of MG-63 cells as compared with HOB and HOS cells (p < 0.001). There was no significant difference between the activity of the enzyme in HOB and HOS cells. All three cell types also have a small amount of active TG on their surface as determined by the incorporation of biotinylated cadaverine into fibronectin. Cell surface-related tTG was further shown by preincubation of cells with tTG antibody, which led to inhibition of cell attachment. Western blot analysis clearly indicated that the active TG was tTG and immunocytochemistry showed it be situated in the cytosol of the cells. In situ extracellular enzyme activity also was shown by the cell-mediated incorporation of fluorescein cadaverine into extracellular matrix (ECM) proteins. These results clearly showed that MG-63 cells have high extracellular activity, which colocalized with the ECM protein fibronectin and could be inhibited by the competitive primary amine substrate putrescine. The contribution of tTG to cell surface/matrix interactions and to the stabilization of the ECM of osteoblast cells therefore could by an important factor in the cascade of events leading to bone differentiation and mineralization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11499870     DOI: 10.1359/jbmr.2001.16.8.1477

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  15 in total

Review 1.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 2.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

3.  Transglutaminase-mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoprotein.

Authors:  Jennifer Forsprecher; Zhemeng Wang; Harvey A Goldberg; Mari T Kaartinen
Journal:  Cell Adh Migr       Date:  2011-01-01       Impact factor: 3.405

4.  Effect of retinoic acid and vitamin D3 on osteoblast differentiation and activity in aging.

Authors:  Michela Bosetti; Maurizio Sabbatini; Anna Calarco; Alessia Borrone; Gianfranco Peluso; Mario Cannas
Journal:  J Bone Miner Metab       Date:  2015-02-18       Impact factor: 2.626

5.  Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.

Authors:  Aisha Mousa; Cui Cui; Aimei Song; Vamsee D Myneni; Huifang Sun; Jin Jin Li; Monzur Murshed; Gerry Melino; Mari T Kaartinen
Journal:  Cell Death Differ       Date:  2017-04-07       Impact factor: 15.828

6.  Structural Stability of Intelectin-1.

Authors:  John J Kozak; Harry B Gray; Roberto A Garza-López
Journal:  J Phys Chem B       Date:  2016-11-11       Impact factor: 2.991

7.  Use of tissue transglutaminase and fibronectin to influence osteoblast responses to tricalcium phosphate scaffolds.

Authors:  M D Ball; D O'Connor; A Pandit
Journal:  J Mater Sci Mater Med       Date:  2008-08-14       Impact factor: 3.896

8.  Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.

Authors:  Alessandra Scarpellini; Renée Germack; Hugues Lortat-Jacob; Takashi Muramatsu; Ellen Billett; Timothy Johnson; Elisabetta A M Verderio
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

9.  Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation.

Authors:  Kristen A Johnson; David M Rose; Robert A Terkeltaub
Journal:  J Cell Sci       Date:  2008-06-10       Impact factor: 5.285

10.  Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?

Authors:  Miriam E van Strien; John J P Brevé; Silvina Fratantoni; Marco W J Schreurs; John G J M Bol; Cornelis A M Jongenelen; Benjamin Drukarch; Anne-Marie van Dam
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.